Squarepoint Ops LLC Cytokinetics Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 105,807 shares of CYTK stock, worth $5.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

105,807

Previous 8,600 1130.31%

Holding current value

$5.17 Million

Previous $465,000 1101.29%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $5.42 Million - $6.37 Million	105,807 New	105,807 $5.59 Million
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $1.64 Million - $2.78 Million	25,700 New	25,700 $1.8 Million
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $586,556 - $838,101	16,398 New	16,398 $751,000
Q2 2022 Aug 15, 2022	SELL	$33.93 - $48.92 $3.89 Million - $5.6 Million	-114,537 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $2.82 Million - $4.36 Million	94,766 Added 479.32%	114,537 $4.22 Million
Q4 2021 Feb 14, 2022	SELL	$34.35 - $46.38 $2.46 Million - $3.32 Million	-71,644 Reduced 78.37%	19,771 $901,000
Q3 2021 Nov 15, 2021	SELL	$18.54 - $35.74 $1.42 Million - $2.73 Million	-76,333 Reduced 45.5%	91,415 $3.27 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $2.89 Million - $3.94 Million	145,974 Added 670.41%	167,748 $3.32 Million
Q1 2021 May 17, 2021	SELL	$18.57 - $25.68 $992,937 - $1.37 Million	-53,470 Reduced 71.06%	21,774 $506,000
Q4 2020 Feb 16, 2021	BUY	$15.26 - $28.61 $266,988 - $500,560	17,496 Added 30.3%	75,244 $1.56 Million
Q3 2020 Nov 16, 2020	BUY	$20.58 - $28.96 $758,578 - $1.07 Million	36,860 Added 176.46%	57,748 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$11.15 - $24.64 $232,901 - $514,680	20,888 New	20,888 $492,000
Q1 2020 May 15, 2020	SELL	$8.75 - $16.3 $478,905 - $892,131	-54,732 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.95 - $11.84 $499,252 - $743,540	-62,799 Reduced 53.43%	54,732 $581,000
Q3 2019 Nov 14, 2019	BUY	$10.82 - $14.25 $631,098 - $831,159	58,327 Added 98.52%	117,531 $1.34 Million
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $231,623 - $327,768	29,135 Added 96.89%	59,204 $666,000
Q1 2019 May 15, 2019	BUY	$5.95 - $10.19 $109,890 - $188,199	18,469 Added 159.22%	30,069 $243,000
Q4 2018 Feb 14, 2019	BUY	$5.91 - $9.29 $8,498 - $13,359	1,438 Added 14.15%	11,600 $73,000
Q3 2018 Nov 14, 2018	BUY	$6.4 - $9.85 $65,036 - $100,095	10,162 New	10,162 $100,000
Q1 2018 May 15, 2018	SELL	$7.2 - $10.05 $1.01 Million - $1.41 Million	-139,925 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$7.25 - $15.65 $498,466 - $1.08 Million	68,754 Added 96.6%	139,925 $1.14 Million
Q3 2017 Nov 14, 2017	BUY	$12.0 - $15.0 $854,052 - $1.07 Million	71,171	71,171 $1.03 Million

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Cytokinetics Inc Transaction History